United States Nanobodies Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
United States Nanobodies Market is Segmented By Product Type (Monovalent Nanobodies, Bivalent Nanobodies, Bispecific Nanobodies, Biparatopic Nanobodies, Multivalent Nanobodies, Fusion Nanobodies), By Therapeutic Area (Oncology, Infectious Diseases, Inflammatory and Autoimmune Diseases, Neurological Disorders, Others). The report offers the value (in USD Million) for the above-mentioned segments
United States Nanobodies Market Size
Market Size in USD
CAGR17.3%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 17.3% |
| Market Concentration | Medium |
| Major Players | Merck KGaA, Sanofi, GenScript, Numab Therapeutics, CUSABIO TECHNOLOGY LLC |
please let us know !
United States Nanobodies Market Analysis
The United States Nanobodies Market is estimated to be valued at USD 109.87 Mn in 2024 and is expected to reach USD 334.97 Mn by 2031, growing at a compound annual growth rate (CAGR) of 17.3% from 2024 to 2031.
Factors such as increasing investment in research and development for production of nanobodies for various therapeutic applications, rising demand for nanobodies due to their high specificity and ability to target complex epitopes are driving the market growth.